Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes
World Journal of Surgery · 18.11.2026
DOI: 10.1002/wjs.70600 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 18.11.2026. Verfasst von Geraint L. Herbert und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Prehabilitation (prehab) aims to prepare patients for treatment by lowering risk, promoting fitness, and improving outcomes—yet prehab's exact merit is controversial, not least because of conflicting evidence related to study heterogeneity, equity of access, and protocol uniformity. This study aimed to determine prehab's true value in Upper Gastro‐Intestinal cancer surgery—the hypothesis was that prehab would reduce Operative Morbidity (OM), shorten Length of Hospital Stay (LoHS) and improve Overall Survival (OS).
Methods
Consecutive patients were studied prospectively, incorporating propensity score analysis. Primary outcomes were OM, mortality, LoHS, costs per Quality‐Adjusted Life Years (QALYs) and OS.
Results
Consecutive 907 patients undergoing surgery for UGI cancer were included, 182 receiving prehab (median age 67 y, 128 Esophageal Cancer (EC), 54 Gastric Cancer (GC)) and 725 control therapy [67 y, 410 EC, 315 GC]. Prehab OM (Clavien‐Dindo ≥ 3) and mortality were 18.1% and 1.6% versus 20.7% ( p = 0.179) and 2.5% ( p = 0.503) in controls, and median LoHS 11 versus 13 days ( p = 0.007). Two‐year OS after prehab was 67.9 versus 59.1% in controls ( p = 0.027). Multivariable analysis revealed that prehab (HR 0.572, p = 0.012), positive resection margin (HR 1.422, p = 0.003), OM (HR 1.712, p < 0.001) and pTNM stage; complete pathological response p < 0.001, stage II (HR 2.222, p = 0.018), stage III (HR 4.544, p < 0.001) and stage IV (HR 5.926, p < 0.001) were associated with OS. The incremental cost‐effectiveness ratio (ICER; additional cost per QALY gained) for prehab was €1292 for EC and €5406 for GC.
Conclusions
Prehab was associated with significant 2‐day shorter LoHS and 8.8% better OS, with ICERs well below the NICE willingness‐to‐pay threshold, supporting the hypothesis that prehab is cost‐effective.
Zitieren
APA
Herbert, G. L., Barlow, R. C., Powell, A. G., Abdelrahman, T., Fraser, D., Khalid, U., & Lewis, W. G. (2026). Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes. World Journal of Surgery. https://doi.org/10.1002/wjs.70600
Vancouver
Herbert GL, Barlow RC, Powell AG, Abdelrahman T, Fraser D, Khalid U, et al. Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes. World Journal of Surgery. 2026. doi:10.1002/wjs.70600
BibTeX
@article{Herbert2026,
author = {Herbert, Geraint L. and Barlow, Rachael C. and Powell, Arfon G. and Abdelrahman, Tarig and Fraser, Donald and Khalid, Usman and Lewis, Wyn G.},
title = {Prognostic Significance of Prehabilitation in Upper Gastro‐Intestinal Cancer Surgery: A Multivariable and Propensity Score Analysis of Outcomes},
journal = {World Journal of Surgery},
year = {2026},
doi = {10.1002/wjs.70600}
}
EUVIMED